We use cookies and other tools to enhance your experience on our website and to analyze our web traffic.
For more information about these cookies and the data collected, please refer to our Privacy Policy.

Search

dihir2 under Medical History/Medications/SHHS2 in SHHS variables
Participant taking IMMEDIATE-RELEASE DIHYDROPYRIDINES OTHER THAN NIFEDIPINE within two weeks of the Sleep Heart Health Study Visit Two (SHHS2) visit. All medications were recorded during the interview, and medication information was later categorized by physician review.
dihsr2 under Medical History/Medications/SHHS2 in SHHS variables
Participant taking SLOW-RELEASE DIHYDROPYRIDINES OTHER THAN NIFEDIPINE OR AMLOPIDINE within two weeks of the Sleep Heart Health Study Visit Two (SHHS2) visit. All medications were recorded during the interview, and medication information was later categorized by physician review.
diur2 under Medical History/Medications/SHHS2 in SHHS variables
Participant taking ANY DIURETIC within two weeks of the Sleep Heart Health Study Visit Two (SHHS2) visit. All medications were recorded during the interview, and medication information was later categorized by physician review.
dltir2 under Medical History/Medications/SHHS2 in SHHS variables
Participant taking IMMEDIATE-RELEASE DILTIAZEM within two weeks of the Sleep Heart Health Study Visit Two (SHHS2) visit. All medications were recorded during the interview, and medication information was later categorized by physician review.
dltsr2 under Medical History/Medications/SHHS2 in SHHS variables
Participant taking SLOW-RELEASE DILTIAZEM within two weeks of the Sleep Heart Health Study Visit Two (SHHS2) visit. All medications were recorded during the interview, and medication information was later categorized by physician review.
hctz2 under Medical History/Medications/SHHS2 in SHHS variables
Participant taking THIAZIDE DIURETICS WITHOUT K-SPARING AGENTS within two weeks of the Sleep Heart Health Study Visit Two (SHHS2) visit. All medications were recorded during the interview, and medication information was later categorized by physician review.
hctzk2 under Medical History/Medications/SHHS2 in SHHS variables
Participant taking THIAZIDE DIURETICS WITH K-SPARING AGENTS within two weeks of the Sleep Heart Health Study Visit Two (SHHS2) visit. All medications were recorded during the interview, and medication information was later categorized by physician review.
htnmed2 under Medical History/Medications/SHHS2 in SHHS variables
Participant taking ANY ANTI-HYPERTENSIVE MEDICATION within two weeks of the Sleep Heart Health Study Visit Two (SHHS2) visit. All medications were recorded during the interview, and medication information was later categorized by physician review.
kcl2 under Medical History/Medications/SHHS2 in SHHS variables
Participant taking POTASSIUM SUPPLEMENTS within two weeks of the Sleep Heart Health Study Visit Two (SHHS2) visit. All medications were recorded during the interview, and medication information was later categorized by physician review.
kspr2 under Medical History/Medications/SHHS2 in SHHS variables
Participant taking POTASSIUM-SPARING AGENTS ALONE within two weeks of the Sleep Heart Health Study Visit Two (SHHS2) visit. All medications were recorded during the interview, and medication information was later categorized by physician review.
loop2 under Medical History/Medications/SHHS2 in SHHS variables
Participant taking LOOP DIURETICS within two weeks of the Sleep Heart Health Study Visit Two (SHHS2) visit. All medications were recorded during the interview, and medication information was later categorized by physician review.
nifir2 under Medical History/Medications/SHHS2 in SHHS variables
Participant taking IMMEDIATE-RELEASE NIFEDIPINE within two weeks of the Sleep Heart Health Study Visit Two (SHHS2) visit. All medications were recorded during the interview, and medication information was later categorized by physician review.
nifsr2 under Medical History/Medications/SHHS2 in SHHS variables
Participant taking SLOW-RELEASE NIFEDIPINE within two weeks of the Sleep Heart Health Study Visit Two (SHHS2) visit. All medications were recorded during the interview, and medication information was later categorized by physician review.
ntg2 under Medical History/Medications/SHHS2 in SHHS variables
Participant taking NITRATES within two weeks of the Sleep Heart Health Study Visit Two (SHHS2) visit. All medications were recorded during the interview, and medication information was later categorized by physician review.
pvdl2 under Medical History/Medications/SHHS2 in SHHS variables
Participant taking PERIPHERAL VASODILATORS, EXCLUDE DIPYRIDAMOLE within two weeks of the Sleep Heart Health Study Visit Two (SHHS2) visit. All medications were recorded during the interview, and medication information was later categorized by physician review.
vaso2 under Medical History/Medications/SHHS2 in SHHS variables
Participant taking VASODILATORS, A MIXED GROUP within two weeks of the Sleep Heart Health Study Visit Two (SHHS2) visit. All medications were recorded during the interview, and medication information was later categorized by physician review.
vasod2 under Medical History/Medications/SHHS2 in SHHS variables
Participant taking VASODILATORS WITH DIURETICS, A MIXED GROUP within two weeks of the Sleep Heart Health Study Visit Two (SHHS2) visit. All medications were recorded during the interview, and medication information was later categorized by physician review.
verir2 under Medical History/Medications/SHHS2 in SHHS variables
Participant taking IMMEDIATE-RELEASE VERAPAMIL within two weeks of the Sleep Heart Health Study Visit Two (SHHS2) visit. All medications were recorded during the interview, and medication information was later categorized by physician review.
versr2 under Medical History/Medications/SHHS2 in SHHS variables
Participant taking SLOW-RELEASE VERAPAMIL within two weeks of the Sleep Heart Health Study Visit Two (SHHS2) visit. All medications were recorded during the interview, and medication information was later categorized by physician review.
bp11 under Clinical Data/Vital Signs/Seated Blood Pressure in CHAT variables
bp12 under Clinical Data/Vital Signs/Seated Blood Pressure in CHAT variables
bp21 under Clinical Data/Vital Signs/Seated Blood Pressure in CHAT variables
bp22 under Clinical Data/Vital Signs/Seated Blood Pressure in CHAT variables
bp31 under Clinical Data/Vital Signs/Seated Blood Pressure in CHAT variables
bp32 under Clinical Data/Vital Signs/Seated Blood Pressure in CHAT variables